Retrospective Study to Evaluate the Use of Type 1 Bovine Hydrolyzed Collagen to Support Surgical Wound Healing After Spinal Surgery

Abstract

Surgical site infection (SSI) and wound dehiscence are among the most common postoperative spinal surgery complications. Treatment can be complex, costly, and may require hospital readmission. Type 1 Hydrolyzed Collagen (T1HC) powder can be used during surgery to support the healing environment of the surgical wound. This study is a retrospective review of 154 patients who underwent spinal surgery using CellerateRX® Surgical powder. A total of three (1.9%) high-risk patients developed postoperative wound complications (SSI or dehiscence). All complications resolved with local wound care and oral antibiotics; no hospital readmissions were required. This low incidence of surgical complications further supports the use of T1HC as an effective wound therapy agent in spinal surgery.

Reference

Hotchkiss WR (2021) Retrospective Study to Evaluate the Use of Type 1 Bovine Hydrolyzed Collagen to Support Surgical Wound Healing After Spinal Surgery. JSM Neurosurg Spine 8(1): 1103.